RESUMO
AIM: Universal neonatal hearing screening Project started in Albania for the first time in January 2009. It was made possible by the support of Magis, an Italian NGO, as a grant of Italian government to the Albanian health system. The aim of this study was to assess the prevalence of PCHI in Albania. METHODS: Universal neonatal hearing screening in Albania started on January 2009 until December 2012. Overall, 47341 newborns were tested. The screening covered the three main cities of Albania; Tirana, Shkodra and Fier. RESULTS: Overall, 93 babies resulted with bilateral hearing loss after the two steps screening. In total, 85 babies had hearing aids, 8 babies decided to get medical treatment abroad. The incidence at the end of the project is 2.1 babies with bilateral hearing impairment per 1000 births/year (2.1/1000 births). CONCLUSION: Our findings are generally in line with previous reports on this matter. Future studies in Albania should be conducted to assess the prevalence and determinants of PCHI in Albania and in other transitional settings.
RESUMO
BACKGROUND: Cranial ultrasonography is a useful tool to detect intracranial lesions in premature neonates at risk. Our primary aim was to determine the number of patients with abnormal cranial ultrasonography. Secondary aims were to evaluate the usefulness of universal cranial ultrasonography screening in moderately preterm infants. METHODS: All infants born from 2007 to 2012 at the University Hospital of Ferrara (Italy), with gestational age of 33-36 weeks, were included in the study. Cranial ultrasonography findings were retrospectively classified into nonsignificant and significant. RESULTS: All the 724 babies born were screened. Intracranial lesions were in 13% of neonates (3.7% at 36 weeks to 27.1% at 33 weeks of gestational age). Babies born at 33-34 weeks of gestational age were four times more likely to have an abnormal cranial ultrasonography than those at 35-36 weeks. Statistical analysis revealed no association between cranial ultrasonography abnormalities and being small for gestational age or mode of delivery. A significant association was present between the presence of head circumference less than the third percentile, the need for ventilation or surfactant, low Apgar index at fifth minute, and neurological abnormalities. The presence of at least one considered risk factor increases the probability of cranial ultrasonography abnormalities twice in infants born at 33-34 weeks and 15 times in born at 35-36 weeks. CONCLUSIONS: A considerable number of infants born between 33 and 36 weeks have cranial ultrasonography abnormalities. We suggest that screening should be performed or at least that a uniform protocol should be developed for the early detection of all significant cranial ultrasonography abnormalities.
Assuntos
Hemorragia Cerebral/diagnóstico por imagem , Doenças do Prematuro/diagnóstico por imagem , Leucomalácia Periventricular/diagnóstico por imagem , Triagem Neonatal/métodos , Hemorragia Cerebral/epidemiologia , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Doenças do Prematuro/epidemiologia , Itália/epidemiologia , Leucomalácia Periventricular/epidemiologia , Masculino , Estudos Retrospectivos , Crânio/diagnóstico por imagem , UltrassonografiaRESUMO
The universal newborn hearing screening (UNHS) is currently spreading in Germany, as well, even though there can be no talk of a comprehensive establishment. The introduction of UNHS in several federal states such as Hamburg, Hessen, and Schleswig-Holstein can be ascribed to the personal commitment of individual pediatric audiologists. Apart from the procurement of the screening equipment and the training of the staff responsible for the examination of the newborns, the tracking, i.e. the follow-up on children with conspicuous test results, is of utmost importance. This involves significant administration effort and work and is subject to data protection laws that can differ substantially between the various federal states. Among audiologists, there is consensus that within the first three months of a child's life, a hearing loss must be diagnosed and that between the age of 3 and 6 months, the supply of a hearing aid must have been initiated. For this purpose, screening steps 1 (usually a TEOAE measurement) and 2 (AABR testing) need to be conducted in the maternity hospital. The follow-up of step 1 then comprises the repetition of the TEOAE- and AABR measurement for conspicuous children by a specialized physician. The follow-up of step 2 comprises the confirmatory diagnostics in a pediatric audiological center. This always implies BERA diagnostics during spontaneous sleep or under sedation. The subsequent early supply of a hearing aid should generally be conducted by a (pediatric) acoustician specialized on children.